- Home
- AZTR vs AEVAW Comparison
AZTR vs AEVAW Comparison
Compare AZTR & AEVAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTR
- AEVAW
- Stock Information
- Founded
- AZTR 2014
- AEVAW N/A
- Country
- AZTR United States
- AEVAW United States
- Employees
- AZTR N/A
- AEVAW N/A
- Industry
- AZTR Biotechnology: Pharmaceutical Preparations
- AEVAW Auto Parts:O.E.M.
- Sector
- AZTR Health Care
- AEVAW Consumer Discretionary
- Exchange
- AZTR Nasdaq
- AEVAW Nasdaq
- Market Cap
- AZTR 5.0M
- AEVAW 4.0M
- IPO Year
- AZTR 2023
- AEVAW N/A
- Fundamental
- Price
- AZTR $0.37
- AEVAW $0.07
- Analyst Decision
- AZTR
- AEVAW
- Analyst Count
- AZTR 0
- AEVAW 0
- Target Price
- AZTR N/A
- AEVAW N/A
- AVG Volume (30 Days)
- AZTR 17.8M
- AEVAW N/A
- Earning Date
- AZTR 03-14-2025
- AEVAW N/A
- Dividend Yield
- AZTR N/A
- AEVAW N/A
- EPS Growth
- AZTR N/A
- AEVAW N/A
- EPS
- AZTR N/A
- AEVAW N/A
- Revenue
- AZTR $97,500.00
- AEVAW N/A
- Revenue This Year
- AZTR N/A
- AEVAW N/A
- Revenue Next Year
- AZTR N/A
- AEVAW N/A
- P/E Ratio
- AZTR N/A
- AEVAW N/A
- Revenue Growth
- AZTR N/A
- AEVAW N/A
- 52 Week Low
- AZTR $0.23
- AEVAW N/A
- 52 Week High
- AZTR $12.00
- AEVAW N/A
- Technical
- Relative Strength Index (RSI)
- AZTR 51.23
- AEVAW N/A
- Support Level
- AZTR $0.35
- AEVAW N/A
- Resistance Level
- AZTR $0.45
- AEVAW N/A
- Average True Range (ATR)
- AZTR 0.08
- AEVAW 0.00
- MACD
- AZTR 0.01
- AEVAW 0.00
- Stochastic Oscillator
- AZTR 36.26
- AEVAW 0.00
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.